EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteasome Augmentation Mitigates Age‐Related Cognitive Decline in Mice

Danitra Parker, Kanisa Davidson, Pawel A Osmulski, Maria Gaczynska, Andrew M Pickering iD

Aging Cell · 2025-03 · 24 (3)

DOI: 10.1111/acel.14492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 13.02.2025. Verfasst von Danitra Parker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center at Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Cognitive Dysfunction, Aging. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Owens Foundation, American Federation for Aging Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aging brain experiences a significant decline in proteasome function. The proteasome is critical for many key neuronal functions including neuronal plasticity, and memory formation/retention. Treatment with proteasome inhibitors impairs these processes. Our study reveals a marked reduction in 20S and 26S proteasome activities in aged mice brains, including in the hippocampus, this is driven by reduced functionality of aged proteasome. The decline in proteasome activity is matched by a decline in 20S proteasome assembly. In contrast, 26S proteasome assembly was found to increase with age, though 26S proteasome activity was still found to decline. Our data suggests that age‐related declines in proteasome activity is driven predominantly by reduced functionality of proteasome rather than altered composition. By overexpressing the proteasome subunit PSMB5 in the neurons of mice to increase the proteasome content and thus enhance its functionality, we slowed age‐related declines in spatial learning and memory. We then showed acute treatment with a proteasome activator to rescue spatial learning and memory deficits in aged mice. These findings highlight the potential of proteasome augmentation as a therapeutic strategy to mitigate age‐related cognitive declines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteasome Endopeptidase ComplexCognitive DysfunctionAgingAnimalsMiceMaleHippocampusMice, Inbred C57BL

Stichwörter der Autor:innen

aging brainmiceproteasomeproteostasis

Substanzen

Proteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Department of Molecular Medicine, UTHealth San Antonio, San Antonio, Texas, USA.
  • Institute on Aging, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

ORCID-Profile: Andrew M Pickering

Förderung

  • NIA NIH HHS
  • Owens Foundation
  • American Federation for Aging Research
  • National Institute on Aging

Zitieren

APA

Parker, D., Davidson, K., Osmulski, P. A., Gaczynska, M., & Pickering, A. M. (2025). Proteasome Augmentation Mitigates Age‐Related Cognitive Decline in Mice. Aging Cell, 24(3). https://doi.org/10.1111/acel.14492

Vancouver

Parker D, Davidson K, Osmulski PA, Gaczynska M, Pickering AM. Proteasome Augmentation Mitigates Age‐Related Cognitive Decline in Mice. Aging Cell. 2025;24(3). doi:10.1111/acel.14492

BibTeX
@article{Parker2025,
  author = {Parker, Danitra and Davidson, Kanisa and Osmulski, Pawel A and Gaczynska, Maria and Pickering, Andrew M},
  title = {Proteasome Augmentation Mitigates Age‐Related Cognitive Decline in Mice},
  journal = {Aging Cell},
  year = {2025},
  volume = {24},
  number = {3},
  doi = {10.1111/acel.14492}
}
Kostenlos starten →